Mazabraud Yann's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Mar 18, 2025
- Accession no.
- 0001104659-25-025236
- Filed
- Mar 18, 2025
- Trade date
- Mar 14, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.86M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mazabraud YannCIK 0001774702 | Officer (EVP, Head of International) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Common Stock | MOption exerciseAcquired | +75,000 | $22.28 | +$1,671,000 | 115,370 | Direct | |
| Mar 14, 2025 | Common Stock | SSaleDisposed | −19,197 | $50.79 | −$975,015.63 | 96,173 | Direct | |
| Mar 14, 2025 | Common Stock | SSaleDisposed | −55,803 | $51.72 | −$2,886,131.16 | 40,370 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Common Stock | MOption exerciseDisposed | −75,000 | $0.00 | $0 | 25,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.